Bioinformatics Advances,
Journal Year:
2024,
Volume and Issue:
5(1)
Published: Dec. 6, 2024
Understanding
the
conformational
landscape
of
protein-ligand
interactions
is
critical
for
elucidating
binding
mechanisms
that
govern
these
interactions.
Traditional
methods
like
molecular
dynamics
(MD)
simulations
are
computationally
intensive,
leading
to
a
demand
more
efficient
approaches.
This
study
explores
how
multiple
sequence
alignment
(MSA)
clustering
enhance
AF-Multimer's
ability
predict
landscapes,
particularly
proteins
with
states.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 23, 2024
Abstract
Class
B
G
protein-coupled
receptors
can
form
dimeric
complexes
important
for
high
potency
biological
effects.
Here,
we
apply
pharmacological,
biochemical,
and
biophysical
techniques
to
cells
membranes
expressing
the
prototypic
secretin
receptor
(SecR)
gain
insights
into
binding
homo-dimeric
monomeric
SecR.
Spatial
proximity
between
peptide
residues,
probed
by
disulfide
bond
formation,
demonstrates
that
N-terminus
moves
from
adjacent
extracellular
loop
3
(ECL3)
at
wild
type
SecR
toward
ECL2
in
non-dimerizing
mutants.
Analysis
of
fluorescent
analogs
stable
engagement
C-terminal
region
within
domain
(ECD)
both
receptors,
while
mid-region
exhibits
lower
mobility
docked
monomer.
Moreover,
decoupling
protein
interaction
reduces
levels
similar
mutant,
whereas
it
has
no
further
impact
on
These
data
support
a
model
whereby
ability
dimerize
promotes
higher
conformational
dynamics
peptide-bound
ECD
ECLs
likely
facilitates
more
efficient
recruitment
activation,
consistent
with
observed
functional
relative
mutant
receptor.
Biochemical Pharmacology,
Journal Year:
2024,
Volume and Issue:
229, P. 116483 - 116483
Published: Aug. 13, 2024
Class
B1
G
protein-coupled
receptors
(GPCRs)
are
peptide
hormone
and
well
validated
therapeutic
targets,
however
development
of
non-peptide
drugs
targeting
this
class
is
challenging.
Recently,
a
series
isoquinoline-based
derivates
were
reported
in
the
patent
literature
as
allosteric
ligands
for
glucagon
receptor
subfamily,
two
compounds,
LSN3451217
LSN3556672,
used
to
facilitate
structural
studies
with
glucagon-like
peptide-1
(GLP-1R)
glucose
dependent
insulinotropic
(GIPR)
bound
orthosteric
agonists.
Here
we
pharmacologically
characterized
stereoisomers
across
GPCR
family.
This
revealed
LSN3556672
isomers
agonists
(GCGR),
GLP-1R,
GIPR
calcitonin
(CTR),
albeit
degree
agonism
varied
at
each
receptor.
In
contrast,
more
selective
lower
potency
GCGR
CTR
no
activity
GIPR.
All
compounds
also
modulated
peptide-mediated
cyclic
adenosine
monophosphate
(cAMP)
signaling
GIPR,
lesser
extent
probe-dependent
manner,
modest
positive
modulation
observed
some
peptides,
negligible
effects
other
peptides.
contrast
neutral
or
weak
negative/positive
was
peptides
assessed
CTR.
study
expands
our
knowledge
on
may
have
implications
future
drug
discovery
efforts
subfamily.
The
canonical
chemokine
receptor
CXCR4
and
atypical
ACKR3
both
respond
to
CXCL12
but
induce
different
effector
responses
regulate
cell
migration.
While
couples
G
proteins
directly
promotes
migration,
is
protein-
independent
scavenges
extracellular
levels
maintain
responsiveness,
thereby
indirectly
influencing
receptors
also
have
distinct
activation
requirements.
only
responds
wild-type
sensitive
mutation
of
the
chemokine.
By
contrast,
recruits
GPCR
kinases
(GRKs)
β-arrestins
promiscuously
CXCL12,
variants,
other
peptides
proteins,
relatively
insensitive
mutation.
To
investigate
role
conformational
dynamics
in
pharmacological
behaviors
ACKR3,
we
employed
single-molecule
FRET
track
discrete
states
real-time.
data
revealed
that
apo-CXCR4
preferentially
populates
a
high-
inactive
state,
while
apo-ACKR3
shows
little
preference
high
transition
probabilities
among
multiple
inactive,
intermediate
active
conformations,
consistent
with
its
propensity
for
activation.
Multiple
active-like
conformations
are
populated
response
agonists,
compared
single
active-state.
This
markedly
landscapes
suggest
may
be
achieved
by
broader
distribution
than
CXCR4.
Much
heterogeneity
linked
residue
differs
between
dynamic
properties
underly
inability
form
productive
interactions
would
drive
signaling.
eLife,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 21, 2024
The
canonical
chemokine
receptor
CXCR4
and
atypical
ACKR3
both
respond
to
CXCL12
but
induce
different
effector
responses
regulate
cell
migration.
While
couples
G
proteins
directly
promotes
migration,
is
G-protein-independent
scavenges
extracellular
levels
maintain
responsiveness,
thereby
indirectly
influencing
receptors
also
have
distinct
activation
requirements.
only
responds
wild-type
sensitive
mutation
of
the
chemokine.
By
contrast,
recruits
GPCR
kinases
(GRKs)
β-arrestins
promiscuously
CXCL12,
variants,
other
peptides
proteins,
relatively
insensitive
mutation.
To
investigate
role
conformational
dynamics
in
pharmacological
behaviors
ACKR3,
we
employed
single-molecule
FRET
track
discrete
states
real-time.
data
revealed
that
apo-CXCR4
preferentially
populates
a
high-FRET
inactive
state,
while
apo-ACKR3
shows
little
preference
high
transition
probabilities
among
multiple
inactive,
intermediate
active
conformations,
consistent
with
its
propensity
for
activation.
Multiple
active-like
conformations
are
populated
response
agonists,
compared
single
active-state.
This
markedly
landscapes
suggest
may
be
achieved
by
broader
distribution
than
CXCR4.
Much
heterogeneity
linked
residue
differs
between
dynamic
properties
underly
inability
form
productive
interactions
would
drive
signaling.
Bioinformatics Advances,
Journal Year:
2024,
Volume and Issue:
5(1)
Published: Dec. 6, 2024
Understanding
the
conformational
landscape
of
protein-ligand
interactions
is
critical
for
elucidating
binding
mechanisms
that
govern
these
interactions.
Traditional
methods
like
molecular
dynamics
(MD)
simulations
are
computationally
intensive,
leading
to
a
demand
more
efficient
approaches.
This
study
explores
how
multiple
sequence
alignment
(MSA)
clustering
enhance
AF-Multimer's
ability
predict
landscapes,
particularly
proteins
with
states.